Evidence map›Paper›PMID 32754967›Full record

ArticleJournal of clinical laboratory analysis2020

Laboratory verification of an RT-PCR assay for SARS-CoV-2.

Yingping Wu, Wei Xu, Zhiqiang Zhu, Xiaoping Xia

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical laboratory analysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Dengue amid COVID-19 pandemic.PLOS global public health · 2023
    Article
  4. Article
  5. Evaluation of Alternative Transport Media for RT-qPCR-Based SARS-CoV-2 Testing.International journal of analytical chemistry · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Laboratory verification of an RT-PCR assay for SARS-CoV-2.Journal of clinical laboratory analysis · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Yingping WuDepartment of Clinical Laboratory, Fourth Affiliated Hospital of Zhejiang University School of Medicine, Jinhua, China.ORCID https://orcid.org/0000-0002-3456-7705
Wei XuDepartment of Clinical Laboratory, Fourth Affiliated Hospital of Zhejiang University School of Medicine, Jinhua, China.
Zhiqiang ZhuDepartment of Clinical Laboratory, Fourth Affiliated Hospital of Zhejiang University School of Medicine, Jinhua, China.
Xiaoping XiaDepartment of Clinical Laboratory, Fourth Affiliated Hospital of Zhejiang University School of Medicine, Jinhua, China.
Anhui Medical University · CN

Funding

Jinhua Science and Technology Bureau 2020XG-28
6 · The paper itself

Abstract

backgroundReverse transcription-polymerase chain reaction (RT-PCR) is an extremely common clinical method for detecting pathogens, particularly for emerging infectious diseases such as the new coronavirus disease (COVID-19). Currently, detection of the RNA from the novel coronavirus SARS-CoV-2 is the gold standard for establishing a COVID-19 diagnosis. This study evaluates the characteristic performance of the analytical system in a clinical laboratory.

methodsA commercial SARS-CoV-2 RNA RT-PCR Kit used in a clinical laboratory is assessed based on ISO 15189 verification requirements. A multiple real-time RT-PCR assay for the RdRP, N, and E genes in SARS-CoV-2 is verified.

resultsThe analytical system exhibits good analytical sensitivity (1000 copies/mL) and specificity (100%); however, the values of 86.7% and 100% for analytical accuracy deserved attention, compared with two other types of methods. Overall, the kit is potentially useful for SARS-CoV-2 diagnostic testing and meets the verification requirements.

conclusionCompliance with international standards, such as ISO 15189, is valuable for clinical laboratories and for improving laboratory medicine quality and safety. Normalization is essential for obtaining reliable results from the SARS-CoV-2 RNA RT-PCR assay. This study aims to develop an improved SARS-CoV-2 verification framework compared with traditional molecular diagnostic methods, given the urgency of implementing new assays in clinical laboratories.

Indexed as

Clinical Laboratory TechniquesMolecular Diagnostic TechniquesReverse Transcriptase Polymerase Chain ReactionBetacoronavirusCoronavirus InfectionsCOVID-19COVID-19 TestingCOVID-19 VaccinesHumansLimit of DetectionPandemicsPneumonia, ViralQuality ControlReproducibility of ResultsRNA, ViralSARS-CoV-2Covid-19 aAPC vaccineCOVID-19 VaccinesRNA, Viralclinical laboratoryISO 15189quality controlSARS-CoV-2verification

Identifiers

PMID32754967
PMCPMC7435359
OpenAlexW3047440472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.